{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:48:02Z","timestamp":1772804882134,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.placenta.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T01:45:03Z","timestamp":1549244703000},"page":"28-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development"],"prefix":"10.1016","volume":"84","author":[{"given":"Carole-Anne","family":"Whigham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-7745","authenticated-orcid":false,"given":"Teresa M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib1","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1073\/pnas.0637450100","article-title":"mRNA of placental origin is readily detectable in maternal plasma","volume":"100","author":"Ng","year":"2003","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib2","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.1210\/jc.2012-2468","article-title":"Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction","volume":"98","author":"Whitehead","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.placenta.2019.02.002_bib3","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1210\/jc.2011-1233","article-title":"Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia","volume":"96","author":"Paiva","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.placenta.2019.02.002_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1741-7015-11-256","article-title":"Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status","volume":"11","author":"Whitehead","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.placenta.2019.02.002_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/JBB\/2006\/69616","article-title":"MicroRNAs in gene regulation: when the smallest governs it all","volume":"2006","author":"Ouellet","year":"2006","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib6","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/nar\/gki567","article-title":"Clustering and conservation patterns of human microRNAs","volume":"33","author":"Altuvia","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.placenta.2019.02.002_bib7","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/hmg\/ddq272","article-title":"The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta","volume":"19","author":"Noguer-Dance","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.placenta.2019.02.002_bib8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1101\/gr.2743304","article-title":"A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain","volume":"14","author":"Seitz","year":"2004","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.placenta.2019.02.002_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.placenta.2012.05.009","article-title":"MicroRNA expression profiles of trophoblastic cells","volume":"33","author":"Morales-Prieto","year":"2012","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajpath.2011.04.035","article-title":"miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies","volume":"179","author":"Lee","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.placenta.2019.02.002_bib11","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1096\/fj.09-149724","article-title":"MiR-205 silences MED1 in hypoxic primary human trophoblasts","volume":"24","author":"Mouillet","year":"2010","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.placenta.2019.02.002_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078487","article-title":"Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero","volume":"8","author":"Whitehead","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.placenta.2019.02.002_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pd.4934","article-title":"Measuring circulating placental RNAs to non-invasively assess the placental transcriptome and to predict pregnancy complications","volume":"36","author":"Whitehead","year":"2016","journal-title":"Prenat. Diagn."},{"issue":"6","key":"10.1016\/j.placenta.2019.02.002_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0002-9378(76)90518-4","article-title":"Serum human chorionic gonadotropin levels throughout normal pregnancy","volume":"126","author":"Braunstein","year":"1976","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2019.02.002_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-0528.1996.tb09765.x","article-title":"Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy","volume":"103","author":"Wald","year":"1996","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.placenta.2019.02.002_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12884-015-0608-y","article-title":"Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis","volume":"15","author":"Zhong","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.placenta.2019.02.002_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2393-8-33","article-title":"Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis","volume":"8","author":"Morris","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.placenta.2019.02.002_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.5165","article-title":"First\u2010trimester biochemical markers of aneuploidy and the prediction of small\u2010for\u2010gestational age fetuses","volume":"31","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijgo.2015.09.022","article-title":"Correlation of first\u2010trimester serum levels of pregnancy\u2010associated plasma protein A with small\u2010for\u2010gestational\u2010age neonates and preterm births","volume":"133","author":"Gundu","year":"2016","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.placenta.2019.02.002_bib20","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.96.6.3149","article-title":"The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A","volume":"96","author":"Lawrence","year":"1999","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.placenta.2019.02.002_bib21","doi-asserted-by":"crossref","first-page":"32382","DOI":"10.1038\/srep32382","article-title":"Altered biomarkers in trophoblast cells obtained noninvasively prior to clinical manifestation of perinatal disease","volume":"6","author":"Bolnick","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cll.2016.01.006","article-title":"Maternal serum analytes as predictors of fetal growth restriction with different degrees of placental vascular dysfunction","volume":"36","author":"Blitz","year":"2016","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.placenta.2019.02.002_bib23","series-title":"Human Chorionic Gonadotropin","first-page":"299","author":"Canfield","year":"1976"},{"issue":"12","key":"10.1016\/j.placenta.2019.02.002_bib24","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/14767058.2016.1214709","article-title":"Adverse fetal outcome: is first trimester ultrasound and Doppler better predictor than biomarkers?","volume":"30","author":"Kumar","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"5","key":"10.1016\/j.placenta.2019.02.002_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.placenta.2019.02.002_bib26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.placenta.2019.02.002_bib27","first-page":"1266","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.5184","article-title":"Predictive value of angiogenic factors and uterine artery Doppler for early\u2010versus late\u2010onset pre\u2010eclampsia and intrauterine growth restriction","volume":"31","author":"Crispi","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2352-4642(18)30129-9","article-title":"Screening for fetal growth restriction using ultrasound and the sFLT1\/PlGF ratio in nulliparous women: a prospective cohort study","volume":"2","author":"Gaccioli","year":"2018","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"1","key":"10.1016\/j.placenta.2019.02.002_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.placenta.2019.02.002_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","article-title":"Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth","volume":"58","author":"Jebbink","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib32","first-page":"69","article-title":"Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis","volume":"23","author":"Palmer","year":"2017","journal-title":"Mol. Hum. Reprod."},{"issue":"6","key":"10.1016\/j.placenta.2019.02.002_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2352-4642(18)30129-9","article-title":"Screening for fetal growth restriction using ultrasound and the sFLT1\/PlGF ratio in nulliparous women: a prospective cohort study","volume":"2","author":"Gaccioli","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib35","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.placenta.2019.02.002_bib38","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/S0021-9258(19)38983-5","article-title":"Epidermal growth factor","volume":"265","author":"Carpenter","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.placenta.2019.02.002_bib39","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","article-title":"BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources","volume":"10","author":"Wu","year":"2009","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.placenta.2019.02.002_bib40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AOG.0b013e3182a1ba56","article-title":"Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth","volume":"122","author":"Nilsson","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"14","key":"10.1016\/j.placenta.2019.02.002_bib41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2217\/nnm.15.48","article-title":"Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy","volume":"10","author":"Keelan","year":"2015","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.placenta.2019.02.002_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/en.2012-1832","article-title":"Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies","volume":"154","author":"Kaitu'u-Lino","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib44","doi-asserted-by":"crossref","first-page":"e1005831","DOI":"10.1371\/journal.ppat.1005831","article-title":"Placental sequestration of Plasmodium falciparum malaria parasites is mediated by the interaction between VAR2CSA and chondroitin sulfate A on syndecan-1","volume":"12","author":"Pereira","year":"2016","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.placenta.2019.02.002_bib45","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.7150\/thno.22904","article-title":"Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.placenta.2019.02.002_bib46","doi-asserted-by":"crossref","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","article-title":"Tumor-homing peptides as tools for targeted delivery of payloads to the placenta","volume":"2","author":"King","year":"2016","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.placenta.2019.02.002_bib47","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.7150\/thno.18845","article-title":"Placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of intrinsic placental growth signaling","volume":"7","author":"Beards","year":"2017","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.placenta.2019.02.002_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nnano.2011.41","article-title":"Silica and titanium dioxide nanoparticles cause pregnancy complications in mice","volume":"6","author":"Yamashita","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib49","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2217\/nnm-2015-0012","article-title":"Nanoparticle transport across the placental barrier: pushing the field forward!","volume":"11","author":"Muoth","year":"2016","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.placenta.2019.02.002_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.placenta.2019.02.002_bib51","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.placenta.2019.02.002_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat. Biotechnol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400418312037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400418312037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:59:33Z","timestamp":1758909573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400418312037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":52,"alternative-id":["S0143400418312037"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2019.02.002","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}